Amid all the enthusiasm, I think it’s the long term shareholders holders who are being done over here
We funded the trials, we took the risk, we have held true to the science, we have waited patiently
We have also de-risked the drug and now Fund Managers will be buy up to 40% at bargain basement price. We did it for patients, we did it for possible rewards but we didn’t do it to have our capital sprayed up a wall
The writing was on the wall when the Directors gave themselves 1c Options with the shadow of the post of the trial outcomes
We are not being treated properly, we have to find out what is happening from newspapers and we are about to be diluted for our loyalty
A disgraceful outcome to such a positive breakthrough!
ATH Price at posting:
1.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)